Objectives Quantitative magnetic resonance imaging (MRI) can potentially meet the pressing need for objective, sensitive, reproducible outcome measures in neuromuscular disease trials. We tested, in healthy volunteers, the consistency, reliability and sensitivity to normal inter-subject variation of MRI methods targeted to lower limb muscle pathology to inform the design of practical but comprehensive MRI outcome measure protocols for use in imminent patient studies. Methods Forty-seven healthy volunteers, age 21-81 years, were subject at 3T to three-point Dixon fat-fraction measurement, T 1 -relaxometry, T 2 -relaxometry and magnetisation transfer ratio (MTR) imaging at mid-thigh and mid-calf level bilaterally. Fifteen subjects underwent repeat imaging at 2 weeks. Results Mean between-muscle fat fraction and T 2 differences were small, but significant (p<0.001). Fat fraction and T 2 correlated positively, and MTR negatively with subject age in both the thigh and calf, with similar significant correlations with weight at thigh level only (p<0.001 to p<0.05). Scanrescan and inter-observer intra-class correlation coefficients ranged between 0.62-0.84 and 0.79-0.99 respectively. Conclusions Quantitative lower-limb muscle MRI using readily implementable methods was sensitive enough to demonstrate inter-muscle differences (small in health), and correlations with subject age and weight. In combination with high reliability, this strongly supports the suitability of these methods to provide longitudinal outcome measures in neuromuscular disease treatment trials. 
rescan and inter-observer intra-class correlation coefficients ranged between 0.62-0.84 and 0.79-0.99 respectively. Conclusions Quantitative lower-limb muscle MRI using readily implementable methods was sensitive enough to demonstrate inter-muscle differences (small in health), and correlations with subject age and weight. In combination with high reliability, this strongly supports the suitability of these methods to provide longitudinal outcome measures in neuromuscular disease treatment trials. Key points • Quantitative lower limb muscle MRI provides potential outcome measures in neuromuscular diseases • Bilateral thigh/calf coverage using sequences sensitive to acute and chronic pathology • Measurements have excellent scan-rescan and interobserver reliability • Measurements show small but significant inter-subject age and weight dependency • Readily implementable sequences suitable for further assessment in patient studies 
Introduction
Imminent clinical treatment trials for neuromuscular diseases (NMDs) [1, 2] need valid, sensitive and reliable treatment response measures [3] . Conventional outcome measures, including muscle strength, neurophysiology and functional assessment are insufficiently sensitive [2] : NMDs typically progress slowly against a background of age-related changes [4] , with therapies more likely to reduce progression than reverse established injury. There is a pressing need for outcome measures reflecting underlying pathological processes with demonstrable longitudinal sensitivity and applicability in multi-centre trials. Systematic assessment of feasibility, reproducibility and normal variation in healthy volunteers is a logical first step in establishing such measures. Conventional magnetic resonance imaging (MRI) can delineate both acute and chronic muscle pathology: acute denervation [5] and inflammation [6] cause oedema-related T 2 -weighted hyper-intensity, typically in early disease and potentially reversible with treatment [7] . Chronic muscle damage, whether caused by a primary myopathy or secondary to a neuropathy, results in atrophy and fatty degeneration [8, 9] , causing T 1 -weighted hyper-intensity, with patterns aiding NMD diagnosis [9] .
Quantitative MRI can objectively measure these changes: on T 2 relaxometry muscle T 2 is elevated in myotonic dystrophy [10] , Duchenne muscular dystrophy [11] , juvenile dermatomyositis [6] and amyotrophic lateral sclerosis [12] , while skeletal muscle magnetisation transfer ratio (MTR) is decreased in limb girdle muscular dystrophy [13] and CharcotMarie-Tooth disease [14] . Muscle fat content has been quantified by T 1 -relaxometry [15] , proton spectroscopy ( 1 H-MRS) [16] [17] [18] [19] , T 2 relaxation modelling [20] [21] [22] and chemical-shift based Dixon fat-water separation [23] providing maps of the proportion of fat to water, or "fat fraction" (FF) [10, 22, [24] [25] [26] .
While these reports support the validity of putative NMD MRI outcome measures, little has been published on potentially confounding age, gender or body mass dependencies [17, 25, 27] , and while inter-or intra-observer reproducibility has been investigated [10, 15, 28] , scan-rescan reproducibility has not been addressed systematically. These factors significantly influence trial statistical sensitivity [3] . Furthermore, studies seldom compare multiple MRI measures in the same subjects, and at both calf-and thigh-levels, having focused mainly on single measures [6, 13, 14, 21, 27, 29, 30] , in either lower leg [10, 13, 21, 26] or thigh [6, 31] , and generally in a single limb rather than bilaterally.
To establish practical NMD MRI trial outcome-measure protocols, we assessed in healthy volunteers a suite of MRI measures expected to be sensitive to NMD muscle pathology. We tested: reproducibility by quantifying scan-rescan and inter-observer reliability, internal consistency by comparing left-and right-limb values, external consistency by comparison with published data and sensitivity to healthy variation by measuring the dependence of lower-limb muscle T 1 , pseudo-T 2 , FF and MTR upon anatomical location and demographic factors, including sex, age and body mass.
Materials and methods

Subjects and MRI examination schedule
With local research ethics committee approval and written consent, 47 healthy volunteers (23 men) were studied: (mean ± SD, range) age 44.4±17.0, 21.5-81.0 years; height 171±9, 150-188 cm; weight 73±16, 44-115 kg; body mass index 25± 4.7, 17-41 kg/m 2 ; 15 undergoing repeat imaging after approximately 2 weeks with identical imaging parameters. The subjects, recruited from friends and family of patients participating in MRI research or the host institution staff, underwent clinical screening to exclude neuromuscular disease prior to examination.
MRI sequence selection
Four MRI measures were chosen for investigation according to their likely sensitivity to both acute (T 2 and MTR) and chronic (T 1 and fat fraction) muscle pathology. Specific measurement pulse sequences and parameters were selected on a pragmatic basis: we chose to select from standard pulse sequences widely available on routinely available imaging platforms with imaging parameters selected to facilitate accurate quantification. For the purposes of the present study it was necessary to obtain wide anatomical coverage of both limbs at thigh and calf level in a practical examination time: this necessitated certain compromises in the acquisition design, such as precluding the use of a Carr-Purcell-Meiboom-Gill multi-echo T 2 -measurement sequence.
MRI acquisition
Subjects were examined lying feet-first and supine at 3T (TIM Trio; Siemens, Erlangen, Germany) using a multi-channel peripheral angiography coil (PA Matrix; Siemens) and 'spine matrix' coil elements. Before examination, the distance between the anterior superior iliac spine and the superior border of the patella was measured and thigh-level imaging volumes were centred one-third of this distance above the patella superior border. Calf-level imaging volumes were centred on the point of widest lower leg circumference.
Axial-slice matrices and fields of view (FOVs) were 256× 128 and 400×200 mm (410×205 mm in some subjects) for thigh-level images and 256×120 and 400×188 mm for calflevel images, except for FF acquisitions where matrices were 512×256 and 512×240 pixels respectively. In this healthy volunteer study, fat suppression was not applied in any of the measurements. The total acquisition time was less than 40 min and included the following sequences:
Fat fraction measurement
For Dixon FF measurement [23] , three 2D gradient-echo acquisitions were performed with echo-times (TEs) (TE 1 [23] , underwent phase unwrapping using the PRELUDE tool, which is part of the FSL software (FMRIB, Oxford) [32] . Each limb in the FOV was processed separately on a 2D individual-slice basis using the TE=3.45 ms magnitude image as a threshold mask. The decomposed fat (F) and water (W) images were then used to calculate FF as FF=100 %×F/(F+ W). The TE=3.45 ms image was used for region of interest (ROI) placement and as a reference for inter-method image registration using FLIRT (FSL, FMRIB, Oxford). 
T 2 -relaxometry
Dual-contrast turbo-spin-echo (TSE) images (TR/TE 1 /TE 2 = 5,500/16/64 ms, 6,500/13/52 ms or 6,500/16/56 ms; 10×10-mm slices with 10-mm gap, parallel imaging factor (iPat) 2, TSE factor 4, BW=444 Hx/pixel, refocusing flip angle 180º, NEX=2) were acquired. Pseudo-T 2 was calculated from the respective pixel intensities I TE1 and I TE2 from the TE 1 [34] .
Magnetisation transfer ratio
MTRs were calculated from two 3D-FLASH images with (M 1 ) and without (M 0 ) an MT pre-pulse (500°amplitude, 1,200 Hz offset, 10 ms duration) (TR/TE=65/3 ms or 68/ 3 ms, α=10º, BW=440 Hz/pixel, iPat=2, 40×5-mm longitudinal phase encoding partitions) according to MTR=(M 0 -M 1 )/M 0 ×100 percentage units (p.u.). MTR maps were RFinhomogeneity corrected using B 1 maps obtained as described in "B1 mapping" above according to [35] using a mean-overall-subjects B 1 inhomogeneity correction factor of k=0.0085.
ROI analysis
A single observer (A.F.; a radiologist with 4 years postspecialist experience in neuromuscular imaging) defined ROIs outlining the cross-sectional area of each muscle avoiding contamination with fascia or subcutaneous and intermuscular fat and allowing for minor movement between acquisitions, using ITK-SNAP [36] . The fifth-most superior slice was used in the thigh and the sixth slice in the calf, unless muscles below were not visible, in which case an adjacent slice was selected. In the 15 subjects with repeated imaging, ROIs for the second acquisition were drawn on the slice most similar to that used from the first acquisition.
Left and right limb ROIs were defined for the rectus femoris, vastus lateralis, vastus intermedius, vastus medialis, semimembranosus, semitendinosus, biceps femoris, adductor magnus, sartorius, gracilis, tibialis anterior, peroneus longus, lateral gastrocnemius, medial gastrocnemius, soleus and tibialis posterior muscles (Fig. 1a) . The ROIs were transferred to the co-registered parameter maps, minor position adjustments to account for imperfect registration were performed as necessary and the mean value for each muscle ROI was recorded. To provide summary measures, the mean of all individual-muscle ROI-means for each subject was calculated for each measure separately at thigh and at calf level. To assess inter-observer reliability, a second observer (J.M.; a neurologist with 3 years' experience in neuromuscular imaging) independently defined ROIs using the same method on one acquisition from each of the 15 subjects with repeat examinations. Image data were inspected visually and ROI values originating from areas of gross artefact were excluded from the analysis.
Statistics
Using SPSS 18 (SPSS, Chicago, IL), inter-muscle differences were assessed using ANOVA with post hoc comparisons using Bonferroni's method. Inter-scan and inter-observer overall mean value differences were assessed using paired ttests and reproducibility determined as mean absolute interscan and inter-observer differences, displayed on BlandAltman plots with calculation of limits of agreement [37] and intra-class correlation coefficients (ICCs). Multivariate regression assessed the influence of demographic factors (age, gender, weight, height) on MRI measures: height showed no independent correlation with any MRI measure and was therefore excluded from the model. Pearson's correlation coefficients between MRI measures were calculated.
Results
Data quality
The number of images excluded from the analysis was small: nine data-sets were missing or technically non-analysable: FF-thigh 1, calf 1; T 1 -thigh 2, calf 4; T 2 -none, MTRcalf 1. In the remaining data, small fractions of individual ROIs were excluded due to local artefact, mostly B 1 -related signal drop-out: FF-thigh 1.7 % (16/920), calf 2.4 % (13/ 540); T 1 -thigh 24 % (219/900), calf 12 % (57/492); T 2 -thigh 5.4 % (51/940), calf 0.2 % (1/552), MTR-thigh 15 % (142/920), calf 5.2 % (28/540). In all subjects, asymmetric B 1 deviations were observed (Fig. 1b) with B 1 reduced anteriorly on the right and posteriorly on the left. This was evident at the calf level but more prominent in the thigh, particularly affecting the right rectus femoris and vastus medialis. This artefact prevented measurement within right rectus femoris in 45/ 47 T1 maps, 41/47 MTR maps and within right vastus medialis in 35/47 T1 maps and 33/47 MTR maps.
Individual muscle values MRI parameter maps from a representative subject are depicted in Fig. 2 . Individual muscle values for each MRI measure in all 47 subjects are shown in Fig. 3 . FF and T 2 were similar in the left and right limbs, suggesting asymmetric B 1 variations did not unduly influence these measures. Between muscles, FF differed significantly (ANOVA, p<0.001 at both calf-and thigh-level). Group-mean sartorius FF was higher than all other thigh-level muscles (p < 0.01 for semimembranosus, p<0.001 for all other muscles), whilst the rectus femoris FF was lower than most other thigh muscles (p<0.01 vs gracilis, vastus lateralis; p<0.001 vs sartorius, semimembranosus, biceps femoris and adductor magnus). Similarly, in the calf soleus the FF was highest (p<0.05 vs peroneal, p<0.01 vs medial gastrocnemius, p<0.001 vs each remaining muscle), whilst tibialis anterior FF was the smallest (p<0.01 vs medial and lateral gastrocnemius, p<0.001 vs soleus and peroneal). However, the absolute inter-muscle differences were small; FF ranging from 0.6 % in the rectus femoris to 2.9 % in the sartorius. Inter-muscle T 2 differences were also significant (ANOVA, p<0.001 at both calf and thigh-level), with the same muscles (sartorius, semimembranosus and biceps femoris in the thigh; soleus, peroneal in the calf) showing elevated T 2 as elevated FF. Whilst tibialis posterior and tibialis anterior T 2 times were lowest in the calf, consistent with their low FF, gracilis T 2 was lowest despite this muscle's intermediate FF.
MTR showed apparent left-right differences in some regions with lower values for right tibialis anterior, right rectus femoris and left semimembranosus, corresponding to the areas of maximum B 1 deviation. Excepting these ROIs, MTR was similar across all thigh and calf muscles (range, 31.7-33.2 p.u.). Mean T 1 similarly varied between left and right limbs in these muscles suggesting incomplete B 1 inhomogeneity correction, but was otherwise consistent across the remaining muscles (1,240-1,370 ms). Table 1 , with interobserver reliability in Table 2 . Mean values are shown for both summary measures and individual-muscle ROI values, together with scan-rescan and inter-observer ICCs and limits of agreement for both. ICCs were 0.84-0.99 for inter-observer and 0.62-0.99 for scan-rescan values, and were generally higher for the summary measures than for the individual muscle values. The limits of agreement were consistently narrower for overall mean values and inter-observer comparisons than for individual ROI values and inter-scan comparisons. The limits of agreement were broadly similar when each muscle was analysed separately (ESM Table 1 ).
Dependence upon age, gender and weight
Results of multivariate linear regression modelling the MRI measures at each level against the assumed explanatory variables age, gender and weight are shown in Table 3 for the allmuscle summary measures, and for individual muscles in ESM Table 2 . There were significant positive dependencies of both FF and T2 upon age at both anatomical levels, and upon weight in the thigh but not calf. MTR showed strong negative dependence upon age (p<0.001) for both thigh and calf (see also Fig. 4 , illustrating the univariate Pearson correlation between overall muscle mean MTR and age), and significant correlation with weight and notably gender in the thigh. T 1 did not depend significantly upon any demographic parameter, except for an association with weight in the thigh only (p<0.05). Although FF correlated positively with T 2 , and negatively with T 1 and MTR (Table 4) , the MTR-age correlation remained significant when the other quantitative parameters were included as covariates (p < 0.01 thigh, p<0.001 calf). We also constructed multivariate linear regression models for individual muscles (ESM Table 2 ), most consistently demonstrating positive correlations between FF or T 2 and weight in the thigh, and negative correlations between MTR and age/gender/weight in the thigh, and age in the calf.
Discussion
We demonstrated the reproducibility of 3T MRI lower limb muscle T 1 , T 2 , MTR and FF obtained using routinely available acquisition sequences suitable for deployment in NMD treatment trials. With the exception of T 1 and MTR in areas of poor B 1 homogeneity, we obtained literature-consistent measurements with good internal consistency, and demonstrated dependence upon specific muscle compartment, age and weight in healthy individuals. Since changes in these measures with muscle disease are expected to far exceed the variations in health we report, combinations of these measurements targeted to disease-specific anatomical levels may offer robust trial outcome measures sensitive to pathological change.
Inter-muscle variation and comparison with previous studies
We observed small but significant inter-muscle T 2 and FF differences, including hamstring FF exceeding quadriceps FF [22] , and increased soleus T 2 compared with tibialis anterior, consistent with previous results [22, 25, 26, 38] to differing proportions of type 1 muscle fibres [39] with increased intra-myocellular lipid [38] . For outcome assessment, this anatomical specificity far exceeds that provided by non-imaging outcome measures such as myometry [40] and neurophysiology [41] . Excepting those muscles for which B 1 deviations were too severe for effective correction, MTRs were consistent with previous calf-muscle studies [13, 25] . All measurements showed good left-right internal consistency except T 1 and MTR in areas of maximum B 1 variation where correction was impossible or proved inadequate.
Reproducibility
The inter-scan limits of agreement provide a measure of sensitivity to detect meaningful change; e.g. for the thighlevel, a change in the overall mean measures in FF, T 2 , T 1 or MTR of +0.28 %, +1.8 ms, -39 ms or -1.63 p.u. is a significant change at the 95 % level for an individual subject. Rates of change of these with specific NMD progression will be confirmed in future natural history studies, but the detectable change thresholds our data suggest are small compared with [10, 14, 15, 21, 22] and are in the range of 1-year changes in oculopharyngeal muscle dystrophy [42] .
Inter-scan differences exceeded inter-observer differences as a source of variation, the former potentially driven by small scan-scan position inconsistencies. Compliance with a predefined positioning protocol could improve scan-scan consistency [43] . Mean all-muscle summary measures provide superior reliability to individual muscle measures; an approach which would be appropriate in NMD with diffuse rather than specific muscle involvement. Rather than assessing scan-scan reproducibility in the same session [17] , a 2-week rescan interval was chosen to better simulate clinical trial conditions whilst being short enough that a true underlying physiologically-driven change in muscle MRI properties was unlikely. We did not explicitly check for factors such as recent exercise [29, 44] or diet [19] , known to influence muscle T 2 and fat content respectively. Nevertheless, high reproducibility and the ability to demonstrate subtle age, weight and gender dependencies suggest that, in practice, metabolic perturbations due to typical exercise and diet regimes are small. Thus, these factors are unlikely to confound quantification of muscle pathology, an observation important for experimental trials where such factors may be hard to control.
Age, gender and body-weight dependencies Correlation of candidate MRI measure values with age, weight and gender is important, firstly, as such factors provide plausible surrogates for disease-related changes, usefully evidencing potential outcome measure validity. Conversely these dependencies, if severe, may confound imaging assessment of outcome by masking changes due to disease. In our healthy volunteers, consistent with age-related impaired muscle strength and neurophysiological performance [4, 45] , muscle MTR reduced while T 2 and FF increased with age in both thigh and lower leg muscles. Schwenzer et al. [25] also demonstrated increases in calf-level FF and T 2 in older subjects, but not MTR. Our contrasting MTR observation may be due to acquisition condition differences, or the advantage of performing B 1 correction [35] in our study. MTR was the measure most sensitive to demographic factors, the negative correlation with age being highly significant (p<0.01) for both overall means, and many individual muscles. The correlation remained significant in a model with T 2 and FF included as covariates, suggesting an MTR age-dependence independent of age-related muscle lipid increases, presumably reflecting myofibre quality and density changes. Future studies involving fat-suppressed or IDEAL-based measurement [46] may conclusively identify muscle-tissue water variations independent of lipid content change. The significant associations between FF, T 2 and MTR with weight, and also between MTR and gender, in the thigh, none of which were observed in the calf-level muscle groups, presumably reflect preferential lipid accumulation in the thigh. These quantitative imaging findings are consistent with muscle lipid increases with weight [17, 18] but not gender [27] on 1 H-MRS. In any case, these demographically driven differences are smaller than the expected pathological changes in NMDs, and thus too small to pose a significant finding in longitudinal studies. This is in contrast with the typically wide variation present in the healthy population for neurophysiology and myometry outcome measures.
Feasibility/study limitations
To allow for straightforward application in future multisite trials, we chose to test sequences readily implemented on standard MRI systems with unmodified software, and which can provide reasonable anatomical coverage in practical examination times. This necessarily limited the measurement sophistication, e.g. multi-echo T 2 measurement sequences allowing analysis of multiple T 2 decay components [29] did not meet the criteria of ready availability and anatomical coverage versus acquisition time. Nevertheless the sequences chosen were adequate to provide sensitive and reproducible measures of FF, T 2 and MTR relevant to muscle pathology.
A challenge in lower-limb quantitative MRI is the inherent B 1 inhomogeneity, particularly at field strengths of 3T and higher. While the dual-contrast TSE T 2 -relaxometry and Dixon FF measurements used here were reasonably insensitive to this, even with B 1 -correction MTR and T 1 -relaxometry data were compromised in regions of maximum B 1 deviation. Despite this we were able to demonstrate strong muscle-MTR dependencies upon age, weight and gender. In this study, T 1 was the least reproducible measure, the least sensitive to demographic variations, and did not add explanatory power for these factors. We conclude that lower-limb muscle T 1 obtained using the DESPOT-1 relaxometry method may not be useful as an NMD outcome measure.
Although the T 1 , T 2 , FF and MTR values and healthy variations we present provide useful reference data to guide the design of future NMD MRI acquisition protocols, the specific absolute values obtained may be partially dependent on sequence design details and field strength. Quality control to ensure consistent inter-site measurement values will be an important first stage in the design of multi-centre trials incorporating MRI outcome measures. The reproducibility and sensitivity to healthy variations we obtained strongly support the potential applicability of these MRI measures to assess longitudinal disease progression.
We demonstrated the feasibility of performing a comprehensive range of MRI measurements in two anatomical levels in both lower limbs. In certain patients such measurements may not provide suitable outcome measures if pathological involvement is minimal, or already progressed to an end-state severity at these levels. Whole-body muscle MRI applications are increasingly being used for diagnostic purposes [47] , and obtaining normative data from all skeletal muscle regions will be a priority in future studies. Natural history studies will identify the anatomical levels where disease progression is actively evolving in specific patient groups, allowing optimally efficient, anatomically-targeted protocols to be tailored to specific trial applications. The resulting reduction in required examination times may be crucial for harmonised use in future multiple-site trials, since long duration acquisitions may represent a problem in NMD patients with for example, cardiac or pulmonary involvement.
Conclusions
Lower-limb muscle T 2 , FF and MTR measures may be obtained using readily implemented methods with sufficient reliability and sensitivity to detect subtle dependencies in health upon biological factors including muscle compartment, age, weight and gender. The observations provide strong suggestive evidence that quantitative MRI can provide practical, anatomically specific outcome measures with less potentially confounding inter-subject variation than current nonimaging measurements.
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